Trademark: 87468467
Word
NAVICAN PRECISION CANCER CARE
Status Date
Tuesday, January 23, 2018
Registration Number
5384399
Registration Date
Tuesday, January 23, 2018
Filing Date
Tuesday, May 30, 2017
Published for Opposition
Tuesday, November 7, 2017
35 Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; and business management of comprehensive programs involving drug therapy
44 Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; and providing an online searchable database in the fields of oncology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer
10 Medical specimen collection kits containing a slide cassette and envelope for collection of cells, tissue, blood, urine, other body fluids and fecal matter
Jan 23, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 14, 2019
Automatic Update Of Assignment Of Ownership
Jan 23, 2018
Registered-Principal Register
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Oct 1, 2017
Assigned To Lie
Sep 16, 2017
Approved For Pub - Principal Register
Aug 26, 2017
Examiner's Amendment Entered
Aug 26, 2017
Notification Of Examiners Amendment E-Mailed
Aug 26, 2017
Examiners Amendment E-Mailed
Aug 26, 2017
Examiners Amendment -Written
Aug 24, 2017
Examiner's Amendment Entered
Aug 24, 2017
Notification Of Examiners Amendment E-Mailed
Aug 24, 2017
Examiners Amendment E-Mailed
Aug 24, 2017
Examiners Amendment -Written
Aug 17, 2017
Assigned To Examiner
Jun 6, 2017
New Application Office Supplied Data Entered
Jun 2, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
